Universal method for the preparation of lipid-based coatings
A process for making lipid-coated substrates including the steps of a. providing a lipid solution (A) of phospholipids in a water miscible organic solvent at a phospholipid concentration between 25 and 450 mg/ml; b. provide an aqueous solution (B) having pH between 4 and 8; c. agitate the aqueous solution (B) and dispense the lipid solution (A) into the aqueous solution (B) to prepare an aqueous dispersion including lipid vesicles (C) having a number average size between 80 and 120 nm (measured according to dynamic light scattering) at a phospholipid concentration between 0.05 mg/ml and 2 mg/ml; and d. applying the aqueous dispersion (C) to a substrate and formation of a lipid-based coating; wherein aqueous dispersion (C) contains at least 95 wt. % water. Medical devices including a lipid-based coating, for example contact lenses and catheters.
1. A process for making lipid-coated substrates comprising the steps of:
a. providing a lipid solution (A) of phospholipids in a water miscible organic solvent at a phospholipid concentration between 25 and 450 mg/ml;
b. providing an aqueous solution (B) having pH between 4 and 8;
c. agitating the aqueous solution (B) and dispense the lipid solution (A) into the aqueous solution (B) to prepare an aqueous dispersion comprising lipid vesicles (C) having a number average size between 80 and 120 nm (measured according to dynamic light scattering) at a phospholipid concentration between 0.05 mg/ml and 2 mg/ml; and
d. applying the aqueous dispersion (C) to a substrate and forming of a lipid-based coating;
wherein aqueous dispersion (C) contains at least 95 wt. % water and,
wherein the aqueous dispersion contains between 0.1 vol % and 1 vol % of an alcohol.
2. The process according to claim 1 , wherein the organic solvent is methanol, ethanol, propanol, acetone, dimethylformamide, glycerol, polyethylene glycol (PEG), or dimethylsulfoxide or any combination thereof.
3. The process according to claim 2 , wherein the organic solvent is an alcohol.
4. The process according to claim 3 , wherein the organic solvent is ethanol.
5. The process according to claim 1 , wherein a temperature of the lipid solution (A) is between −20 and 60° ° C.
6. The process according to 5 , wherein the temperature of the lipid solution (A) is between 10 and 50° C.
7. The process according to 6 , wherein the temperature of the lipid solution (A) is between 15 and 30° C.
8. The process according to claim 1 , wherein the phospholipids are chosen from the group consisting of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and mPEG-phospholipids.
9. The process according to claim 8 , wherein the mPEG-phospholipids are one or more of 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DOPE-PEG2000), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DOPE-PEG2000).
10. The process according to claim 1 , wherein the phospholipids are chosen from the group consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC).
11. The process according to claim 1 , wherein the phospholipids comprise at least one or more PEGylated phospholipids, wherein the PEGylated phospholipids are chosen from the group consisting of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (DSPE-PEG350), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (DSPE-PEG550), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (DSPE-PEG750), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (DSPE-PEG1000), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (DSPE-PEG3000), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (DSPE-PEG5000), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (DOPE-PEG350), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (DOPE-PEG550), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (DOPE-PEG750), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (DOPE-PEG1000), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DOPE-PEG2000), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (DOPE-PEG3000), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (DOPE-PEG5000), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (DPPE-PEG350), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (DPPE-PEG550), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (DPPE-PEG750), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (DPPE-PEG1000), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (DOPE-PEG3000) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (DOPE-PEG5000).
12. The process according to claim 11 , wherein the PEGylated phospholipids are chosen from the group consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DOPE-PEG2000).
13. The process according to claim 1 , wherein the aqueous solution (B) comprises water and optionally salts, buffers, complexing agents and/or water-soluble active or non-active pharmaceutical components.
14. The process according to claim 13 , wherein the salt is present and is one or more of NaCl and CaCl 2 .
15. The process according to claim 1 , wherein the aqueous solution is one or more of milliQ water, demineralized water, phosphate buffered saline (PBS), 2-[4-(2-hydroxyethyl)-piperazin-1-yl]ethane-1-sulfonic acid) (HEPES) buffer, and a saline solution.
16. The process according to claim 1 , wherein a dilution factor of lipid solution (A) in aqueous solution (B) ranges between 100 and 1000, wherein the dilution factor is calculated by dividing the total volume of aqueous solution (B) (before mixing with solution (A)) by the volume of lipid solution (A) to be dosed into the aqueous solution (B).
17. An aqueous dispersion (C), comprising:
phospholipids, wherein the phospholipids are present as vesicles having a number average size between 40 and 140 nm (measured according to dynamic light scattering), wherein the phospholipid concentration ranges between 0.05 and 2.0 mg/ml, wherein the dispersion contains at least 95 wt. % of water, wherein the dispersion contains between 0.1 vol % and 1 vol % of an alcohol, and wherein the phospholipids are chosen from Phosphatidylcholine derivatives, Phosphatidic acid derivatives, Phosphatidylglycerol derivatives, Phosphatidylethanolamine derivatives, Phosphatidylserine derivatives, Natural phospholipid derivatives, polyglycerin-phospholipids, terminal activated-phospholipids, and PEGylated phospholipids, wherein derivatives are fatty acids tails having between 12 and 22 C-atoms.
18. The aqueous dispersion (C) according to claim 17 , wherein the dispersion contains phospholipid vesicles comprise of phosphatidylcholine derivatives and PEGylated phospholipids.
19. The dispersion according to claim 17 , wherein the dispersion (C) contains lipid vesicles comprising of 90-95 mol % (of total phospholipid content) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 5-10 mol % (of total phospholipid content) PEGylated phospholipids and optionally between 0 and 5 mol % (relative to the total phospholipid content) of additives chosen from fluorescent conjugates, proteins, peptides, amphiphiles, ethylene glycol, polyethylene glycol (PEG), ionic polymers, sugar molecules, enzymes and pharmaceutical components.
20. The process according to claim 19 , wherein the PEGylated phospholipid are one or more of 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000) or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DOPE-PEG2000).
21. A method, comprising the step of:
applying the aqueous dispersion (C) according to claim 17 on a medical device, contact lens, catheter, (micro)fluidic device, cell culture device, food production device, or pharma device.
22. An object comprising the lipid-based coating as prepared according to the process of claim 1 .
23. A process for making lipid-coated substrates comprising the steps of:
a. providing a lipid solution (A) of phospholipids in a water miscible organic solvent at a phospholipid concentration between 25 and 450 mg/ml, wherein the water miscible organic solvent is one or more of methanol, ethanol, propanol, acetone, dimethylformamide, glycerol, polyethylene glycol, and dimethylsulfoxide;
b. providing an aqueous solution (B) having pH between 4 and 8;
c. agitating the aqueous solution (B) and dispense the lipid solution (A) into the aqueous solution (B) to prepare an aqueous dispersion comprising lipid vesicles (C) having a number average size between 80 and 120 nm (measured according to dynamic light scattering) at a phospholipid concentration between 0.05 mg/ml and 2 mg/ml; and
d. applying the aqueous dispersion (C) to a substrate and forming of a lipid-based coating;
wherein aqueous dispersion (C) contains at least 95 wt. % water.